Trinogab-M Tablet
Marketer
Navjoie Healthcare
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Trinogab-M Tablet
Gabapentinoid-M tablets are a prescription medication indicated for neuropathic pain management. They alleviate pain by regulating calcium channel function within nerve cells. This medication also safeguards nerve fibers and facilitates the repair of damaged neurons. Gabapentinoid-M tablets are administered orally, with or without food, ideally before sleep. Consistent daily dosing, at the same time, ensures stable therapeutic blood levels. Adhere strictly to the prescribed dosage and duration, as this medication possesses addictive potential. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, regardless of symptom improvement. Abrupt cessation should be avoided without prior consultation with a physician. Commonly reported adverse effects include upper respiratory infection, increased hunger, elevated mood, trembling, visual blurring, dry mouth, lightheadedness, and somnolence. Refrain from operating machinery or engaging in activities requiring concentration until the medication's impact is understood. Side effects are typically mild and resolve spontaneously. Weight gain may occur; regular exercise and a balanced diet are recommended for mitigation. Report any unusual shifts in mood or behavior, emerging or worsening depression, or suicidal ideation to your doctor immediately. Comprehensive disclosure of all other medications currently being used is crucial, as interactions can affect efficacy or alter the drug's action. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Primary Ingredients of Trinogab-M Tablet
No text provided to rephrase.
Uses of Trinogab-M Tablet
Managing neuropathic pain
Major Benefits of Trinogab-M Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Trinogab-M Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Trinogab-M Tablet:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Trinogab-M Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Trinogab-M Tablets can be consumed with or without food; however, consistent timing is recommended.
How Trinogab-M Tablet works:
Trinogab-M tablets contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a vitamin B derivative, supports myelin production, shielding nerve fibers and aiding in the repair of damaged nerve cells. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signaling by modulating nerve cell calcium channel activity. This combined action provides effective relief from the discomfort of nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Trinogab-M tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Trinogab-M tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Trinogab-M tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Trinogab-M tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Trinogab-M tablets. Dosage modifications may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Trinogab-M Tablets in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Trinogab-M Tablet :
Should you forget a dose of Trinogab-M Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trinogab-M Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |



